Etiology of non-insulin-dependent diabetes mellitus: A general overview

Frontiers of Hormone Research

Volumn 22, Issue , 1997, Pages 131-156

  Groop, Leif C ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 54249115114     PISSN: 03013073     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Review

References (133)

1. Alcolado J, Alcolado R: Importance of maternal history of non-insulin dependent diabetic patients. Br Med J 1991;302:1178-1180.
2. Banerji M, Chaiken R, Gordon D, Krai J, Lebovitz H: Does intraabdominal adipose tissue in black men determine whether NIDDM is insulin-resistant or insulin-sensitive? Diabetes 1995;44:141-146.
3. Beck-Nielsen H, Groop L: Metabolic and genetic characterization of prediabetic states. Sequence of events leading to non-insulin-dependent diabetes mellitus. J Clin Invest 1994;94:1714-1721.
4. Bell G, Xiang K-S, Newman M, Wu S-H, Wright L, Fajans S, Spielman R, Cox N: Gene for non-insulin-dependent diabetes mellitus (maturity-onset diabetes of the young subtype) is linked to DNA polymorphism on human chromosome 20q. Proc Natl Acad Sci USA 1991;88:1484-1488.
5. Bennett S, Lucassen A, Gough S, Powell E, Undlien D, Pritchard L, Merriman M, Kawaguchi Y, Dronsfield M, Pociot F, Nerup J, Bouzekri N, Cambon-Thomsen A, Ronningen K, Barnett A, Bain S, Todd J: Susceptibility to human type 1 diabetes at IDDM2 is determined by tandem repeat variation at the insulin gene minisatellite locus. Nature Genet 1995;9:284-292.
6. Borkman M, Storlien L, Pan D, Jenkins A, Chisholm D, Campbell L: The relation between insulin sensitivity and the fatty acid composition of skeletal muscle phospholipids. N Engl J Med 1993;328:238-244.
7. Brosseau J, Eelkema R, Crawford A, Abe T: Diabetes among the three affiliated tribes: correlation with degree of Indian inheritance. Am J Publ Health 1979;69:1277-1278.
8. Byrne M, Sturis J, Fajans S, Javier Ortiz F, Stoltz A, Stoffel M, Smith M, Bell G, Halter J, Polonsky K: Altered insulin secretory responses to glucose in subjects with a mutation in the MODY1 gene on chromosome 20. Diabetres 1995;44:699-704.
9. Cerasi E, Luft R: The plasma insulin response to glucose infusion in healthy subjects and in subjects with diabetes mellitus. Acta Endocrinol 1967;55:278-304.
10. Cleément K, Vaisse C, Manning B, Basdevant A, Guy-Grand B, Ruiz J, Silver K, Shuldiner A, Froguel P, Strosberg A: Genetic variation in the beta3-adrenergic receptor and an increased capacity to gain weight in patients with morbid obesity. N Engl J Med 1995;333:352-354.
11. Coleman D: Effects of parabiosis of obese with diabetes and normal mice. Diabetologia 1973;9:294-298.
12. Coleman D: Obesity genes: Beneficial effects in hetrozygous mice. Science 1979;203:663-665.
13. Collins F: Positional cloning moves from perditional to traditional. Nature Genetics 1995;9:347-350.
14. Consindine R, Consindine E, William C, Nyce M, Magosin S, Bauer T, Rosato E, Colberg J, Caro J: Evidence against either a premature stop codon or the abscence of obese gene raRNA in human obesity: J Clin Invest 1995;95:2986-2988.
15. Consindine R, Sinha M, Heiman M, Kriauciunas A, Stephens T, Nyce M, Ohannesian J, Marco C, McKee L, Bauer T, Caro J: Serum immunoreactive leptin concentrations in normal-weight and obese humans. N Engl J Med 1996;334:292-295.
16. Consoli A, Nurjhan N, Reilly J Jr, Bier D, Gerich J: Mechanisms of increased gluconeogenesis in noninsulin-dependent diabetes mellitus: Role of alterations in systemic, hepatic and muscle lactate and alanine metabolism. J Clin Invest 1990;86:2038-2045.
17. Cook J, Hattersley A, Levy J, Patel P, Wainscoat J, Hockaday D, Turner R: Distribution of type II diabetes in nuclear families. Diabetes 1993;42:106-112.
18. Cook J, Shields D, Page R, Levy J, Hattersley A, Shaw J, Neil H, Wainscoat J, Turner R: Segregation analysis of NIDDM in Caucasian families. Diabetologia 1994;37:1231-1240.
19. Davies J, Kawaguchi Y, Bennett S, Copeman J, Cordell H, Pritchard L, Reed P, Gough S, Jenkins S, Palmer S, Balfour K, Rowe B, Farrall M, Barnett A, Bain S, Todd J: A genome-wide search for human type 1 diabetes-susceptibility genes. Nature 1994;371:130-136.
20. Ekstrand A, Eriksson J, Gronhagen-Riska C, Ahonen P, Groop L: Insulin resistance and insulin deficiency in the pathogenesis of postransplantation diabetes in man. Transplantation 1992;53:563-569.
21. Elbein S, Chiu K, Hoffman M, Mayorga R, Bragg K, Leppert M: Linkage analysis of 19 candidate regions for insulin resistance in familial NIDDM. Diabetes 1995;44:1259-1265.
22. Elbein S, Hoffman M, Ridinger D, Otterud B, Leppert M: Description of a second microsatellite marker and linkage analysis of the muscle glycogen synthase gene locus in familial NIDDM. Diabetes 1994;43:1061-1065.
23. Emorine L, Marullo S, Briend-Sutren M, Patey G, Tate K, Delavier-Klutchko C, Strosberg A: Molecular characterization of the human beta-3-adrenergic receptor. Science 1989;245:1118-1121.
24. Eriksson J, Franssila-Kallunki A, Ekstrand A, Saloranta C, Widén E, Schalin C, Groop L: Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus. N Engl J Med 1989;321:337-343.
25. Eriksson K-F, Saltin B, Lindgärde F: Increased skeletal muscle capillary density precedes diabetes development in men with impaired glucose tolerance. A 15-year follow-up study. Diabetes 1994;43:805-808.
26. Falholt K, I J, Lindkaer Jensen S, Mortenson H, Voelund A, Heding L, Noerskov Petersen P, Falholt W: Carbohydrate and lipid metabolism of skeletal muscle in Type 2 diabetic patients. Diabet Med 1987;5:27-31.
27. Ferrannini E, Buzzigoli G, Bonadonna R, Giorico M, Oleggini M, Pedrinelli R, Brandi L, Bevilacqua S: Insulin resistance in esstential hypertension. N Engl J Med 1987;317:350-357.
28. Forsblom C, Eriksson J, Ekstrand A, Teppo A-M, Taskinen M-R, Groop L: Insulin resistance and abnormal albumin excretion in non-diabetic first-degree relatives of patients with NIDDM. Diabetolgia 1995;38:363-369.
29. Forsén T, Eriksson J, Suhonen L, Teramo K, Groop L: Gestational diabetes-type 2 diabetes with relative insulin deficiency. Duodecim 1994;110:808-814.
30. Froguel P, Vaxillaire M, Sun F, Velho G, Zouali H, Butel M, Lesage S, Vionnet N, Clément K, Fougerousse F, Tanizawa Y, Weissenbach J, Beckman J, Lathrop G, Passa P, Permutt M, Cohen D: Close linkage of glucokinase locus on chromosome 7p to early-onset non-insulin-dependent diabetes mellitus. Nature 1992;356:162-167.
31. Froguel P, Zouali H, Velho G, Vaxillaire M, Sun F, Lesage S, Stoffel M, Takeda J, Passa P, Permutt M, Beckman J, Bell G, Cohen D: Familial hyperglycemia dua to mutations in the glucokinase gene. N Engl J Med 1993;328:697-702.
32. Fujisawa T, Ikegami H, Yamato E, Takekawa K, Nakagawa Y, Hamada Y, Oga T, Ueda H, Shintani M, Fukuda M, Ogihara T: Association of Trp64Arg mutation of the beta3-adrenergic receptor with NIDDM and body weight gain. Diabetologia 1996;39:349-352.
33. Galli J, Li L-S, Glaser A, Östensson C-G, Jiao H, Fakhrai-Rad H, Jacob H, Lander E, Luthman H: Genetic analysis of non-insulin dependent diabetes mellitus in the GK rat. Nature Genetics 12:1996;31-37.
34. Gauguier D, Froguel P, Parent V, Bernard C, Bihoreau M-T, B P, James M, Penicaud L, Lathrop M, Ktorza A: Chromosomal mapping of genetic loci associated with non-insulin dependent diabetes in the GK rat. Nature Genet 1996;12:38-43.
35. Gerbitz K-D, Gempel K, Brdiczka D: Mitochondria and diabetes: Genetic, biochemical, and clinical implications of the cellular energy circuit. Diabetes 1996;45:113-126.
36. Giddings S, King C, Harman K, Flood J, Carnaghi L: Allele specific inactivation of insulin 1 and 2, in the mouse yolk sac indicates imprinting. Nature Genet 1994;6:310-313.
37. Gidh-Jain M, Takeda J, Wu L, Lange A, Vionnet N, Stoffel M, Velho G, Sun F, Cohen D, Froguel P, Patel P, Lo Y-M, Hattersley A, Luthman H, Charles S, Harrison R, Weber I, Bell G, Pilkis S: Glucokinase mutations assocciated with non-insulin-dependent diabetes mellitus (type II) have decreased enzymatic activity: Implications for structure/functions relationships. Proc Natl Acad Sci USA 1993;90:1932-1936.
38. Groop L, Bonadonna R, DelPrato S, Ratheiser K, Zyck K, Ferrannini E, DeFronzo R: Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus: Evidence for multiple sites of insulin resistance. J Clin Invest 1989;84:205-213.
39. Groop L, Bottazzo G: Genetic susceptibility to non-insulin-dependent diabetes mellitus. Brit Med J 1994;308:504.
40. Groop L, Bottazzo G, Doniach D: Islet cell antibodies identify latent type 1 diabetes in patients aged 35-75 years at diagnosis. Diabetes 1986;35:237-241.
41. Groop L, Ekstrand A, Forsblom C, Widén E, Groop P-H, Teppo A-M, Eriksson J: Insulin resistance, hypertension and microalbuminuria in patients with type 2 diabetes mellitus. Diabetologia 1993;36:642-647.
42. Groop L, Ferrannini E: Insulin action and substrate competition. Baillière's Clin Endocrinol Metab 1993;7:1007-1032.
43. Groop L, Forsblom C, Lehtovirta M, Tuomi T, Nissén M, Ehrnström B-O, Forsén B, Isomaa B. Snickars B, Taskinen M-R: Metabolic consequences of a family history of NIDDM (The Botnia Study). 1996; submitted.
44. Groop L, Groop P, Koskimies S: Relationship between beta-cell function and HLA-antigens in patients with type 2 diabetes. Diabetologia 1986;29:757-760.
45. Groop L, Kankuri M, Schalin-Jäntti C, Ekstrand A, Nikula-Ijäs P, Widèn E, Kuismanen E, Eriksson J, Franssila-Kallunki A, Saloranta C, Koskimies S: Association between polymorphism of the glycogen synthase gene and non-insulin-dependent diabetes mellitus. N Engl J Med 1993;328:10-14.
46. Groop L, Widén E, Ferrannini E: Insulin resistance and insulin deficiency in the pathogenesis of type 2 diabetes mellitus: Inborn errors of metabolism or of methods? Diabetologia 1993;36:1326-1331.
47. Gulli G, Ferrannini E, Stern M, Haffner S, DeFronzo R: The metabolic profile of NIDDM is fully established in glucose-tolerant offspring of two Mexican-American parents. Diabetes 1992;41:1575-1586.
48. Hagopian W, Karlsen A, Gottsäter A, Landin-Olsson M, Grubin C, Sundqvist G, Petersen J, Boel E, Dyrberg T, Lernmark Å: Quantitative assay using recombinant human islet glutamic acid decarboxylase (GAD65) shows that 65K autoantibody positivity at onset predicts diabetes type. J Clin Invest 1993;91:368-374.
49. Hales C, Barker D: Type 2 diabetes mellitus: the thrifty phenotype hypothesis. Diabetologia 1992;35:595-601.
50. Hashimoto L, Habita C, Beressi J, Delepine M, Besse C, Cambon-Thomson A, Deschamps I, Rotter J, Djoulah S, James M, Froguel P, Weissenbach J, Lathrop G, Julier C: Genetic mapping of a susceptibility locus for insulin-dependent diabetes mellitus on chromosome 11q. Nature 1994;371:161-164.
51. Himms-Hagen J: Brown adipose tissue thermogenesis, energy balance and obesity. Can J Biochem Cell Biol 1984;62:610-617.
52. Hotamisigil G, Arner P, Caro J, Atkinson R, Spiegelman B: Increased adipose tissue expression of tumor necrosis factor-a in human obesity and insulin resistance. J Clin Invest 1995;95:2409-2415.
53. Hotamisligil G, Shargill N, Spiegelman B: Adipose expression of tumor necrosis factor-a: Direct role in obesity-linked insulin resistance. Science 1993;259:87-91.
54. Hother-Nielsen O, Beck-Nielsen H: Insulin resistance, but normal rates of glucose production in patients with newly diagnosed mild diabetes mellitus. Acta Endocrinol 1991;124:637-645.
55. Hästbacka J, De la Chapelle A, Mahtani M, Clines G, Reeve-Daly M, Daly M, Hamilton B, Kusumi K, Trivedi B, Weawer A, Coloma A, Lovett M, Buckler A, Kaitila I, Lander E: The diastrophic dysplasia gene encodes a novel sulfate transporter: Positional cloning by fine-structure linkage disequilibrium mapping. Cell 1994;78:1073-1087.
56. Kadowaki T, Kadowaki H, Mori Y, Tobe K, Sakuta R, Suzuki Y, Tanabe Y, Sakura H, Awara T, Goto Y-I, Hayakawa T, Matsuoka K, Kawamori R, Kamada T, Horai S, Nonaka I, Hagura R, Akanuma Y, Yazaki Y: A subtype of diabetes mellitus associated with a mutation of mitochondrial DNA. N Engl J Med 1994;330:962-968.
57. Kahn R: Insulin action, diabetogenes, and the cause of type II diabetes. Diabetes 1994;43:1066-1084.
58. Kaprio J, Tuomilehto J, Koskenvuo M, Romanov K, Reunanen A, Eriksson J, Stengard J, Kesaniemi Y: Concordance for type 1 and type 2 diabetes mellitus in a population-based cohort of twins in Finland. Diabetologia 1992;35:1060-1067.
59. Kellerer M, Rett K, Kroder G, Groop L, Haring H: Circulating TNFalfa levels and insulin sensitivity in man. Submitted.
60. Kennedy G, German M, Rutter W: The minisatellite in the diabetes susceptibility locus IDDM2 regulates insulin transcription. Nature Genet 1995;9:293-298.
61. Kopecky J, Clarke G, Enerback S, Spiegelman B, Kozak L: Expression of the imtochondrial uncoupling protein gene from the aP2 gene promoter prevents genetic obesity. J Clin Invest 1995;96:2914-2923.
62. Krief S, Lönnqvist F, Raimbault S, Baude B, Van Spronsen A, Arner P, Strosberg A, Ricquier D, Emorine L: Tissue distribution of beta-3-adrenergic receptor mRNA in man. J Clin Invest 91:1993;344-349.
63. Kuroyama H, Sanke T, Ohangi S, Furuta M, Nanjo K: Simple tandem repeat DNA polymorphism in the human glycogen synthase gene is associated with NIDDM in Japanese subjects. Diabetologia 1994;37:536-539.
64. Köbberling J, Tillil H (eds): Empiricial Risk Figures for First-Degree Relatives of Non-Insulin-Dependent Diabetics. London, Academic Press, 1982, pp 201-209.
65. Laakso M, Barrett-Connor E: Asymtomatic hyperglycemia is associated with lipid and lipoprotein changes favouring atherosclerosis. Arteriosclerosis 1989;9:665-672.
66. Laakso M, Edelman S, Brechtel G, Baron A: Impaired insulin-mediated skeletal muscle blood flow in patients with NIDDM. Diabetes 1992;41:1076-1083.
67. Lee G-H, Proenca R, Montez J, Carroll K, Darvishzadeh J, Lee J, Friedman J: Abnormal splicing of the leptin receptor in diabetic mice. Nature 1996;379:632-635.
68. Lehto M, Stoffel M, Groop L, Espinosa III R, LeBeau M, Bell G: Assignment of the gene encoding gycogen synthase to human chromosome 19, band q13.3. Genomics 1993;15:460-461.
69. Leslie R, Volkmann H, Poncher M, Hanning I, Orskov H, Alberti K: Metabolic abnormalities in children of non-insulin dependent diabetics. Br Med J 1986;293:840-842.
70. Li H, Tuomi T, Orho M, Groop L: Sharing an HLA-haplotype with an IDDM-relative influences insulin secretion in NIDDM and IGT. Diabetes 1996; in press.
71. Lillioja S, Mott D, Howard B, Bennett P, Yki-Järvinen H, Freymond D, Nyomba B, Zurlo F, Swinburn B, Bogardus C: Impaired glucose tolerance as disorder of insulin action. Longitudinal and cross-sectional studies in Pima Indians. N Engl J Med 1987;20:87-93.
72. Lillioja S, Mott D, Spraul M, Ferraro R, Foley J, Ravussin E, Knowler W, Bennett P, Bogardus C: Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. N Engl J Med 1993;329:1988-1992.
73. Lillioja S, Young A, Culter C, Ivy J, Abbott W, Zawadski J, Yki-Järvinen H, Christin L, Secomb T, Bogardus C: Skeletal muscle capillary density and fiber type are possible determinants of in vivo insulin resistance in man. J Clin Invest 1987;80:415-424.
74. Lowell B, Susulic V, Hamman A, Lawitts J, Himms-Hagen J, Boyer B, Kozak L, Flier J: Development of obesity in transgenic mice after genetic ablation of brown adipose tissue. Nature 1993;366:740-742.
75. Lönnqvist F, Thörne A, Nilsell K, Hoffstedt J, Arner P: A pathogenetic role of visceral fat beta-3-adrenoreceptors in obesity. J Clin Invest 1995;95:1109-1116.
76. Maassen J, Kadowaki T: Maternally inherited diabetes and deafness: A new diabetes subtype. Diabetologia 1996;39:375-382.
77. Maassen J, Ouwens D: Mechanism of insulin action; in Leslie RDG (ed): Molecular Pathogenesis of Diabetes mellitus. Front Horm Res. Basel, Karger, 1997, vol 22, pp 201-221.
78. Maffei M, Halaas J, Ravussin E, Pratley R, Lee G, Zhang Y, Fei H, Kim S, Lallone R, Ranganathan S, Kern P, Friedman J: Leptin levels in human and rodent: Measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nature Med 1995;1:1155-1161.
79. Majer M, Mott D, Mochizuki H, Rowles J, Pedersen O, Knowler W, Bogardus C, Prochazka M: Association of the glycogen synthase locus 19q13 with NIDDM in Pima Indians. Diabetologia 1996;39:314-321.
80. Marin P, Rebuffe-Scrive M, Smith U, Bjorntorp P: Glucose uptake in human adipose tissue. Metabolism 1987;36:1154-1160.
81. Martin B, Warram J, Krolewski A, Bergman R, Soeldner J, Kahn C: Role of glucose and insulin resistance in development of type 2 diabetes mellitus: Results of a 25-year follow-up study. Lancet 1992;340:925-929.
82. McCance D, Pettit D, Hanson R, Jakobsson L, Knowler W, Bennett P: Low birth weight and type 2 diabetes in Pima Indians. Diabetologia 1993;36(suppl 1):A5.
83. Mitchell B, Kammerer C, Reinhart L, Stern M, MacCluer J: Is there an excess in maternal transmission of NIDDM? Diabetologia 1995;38:314-317.
84. Mitrakou A, Kelley D, Mokan M, Veneman T, Pangburn T, Reilly J, Gerich J: Role of reduced suppression of glucose production and diminished early insulin release in impaired glucose tolerance. N Engl J Med 1992;326:22-29.
85. Naggert J, Fricker L, Varlamov O, Nishina P, Roille Y, Steiner D, Carroll R, Paigen B, Leiter E: Hyperproinsulinemia in obese fat/fat mice associated with a carboxypeptidase E mutation which reduces enzyme activity. Nature Genet 1995;10:135-142.
86. Neel V: Diabetes mellitus: A 'thrifty' genotype rendered detrimental by progress? Am J Hum Genet 1962;14:352-362.
87. Newman B, Selby J, King M, Slemenda C, Fabsitz R, Friedman G: Concordance for type 2 diabetes in male twins. Diabetologia 1987;30:763-768.
88. Norman R, Bogardus C, Ravussin E: Linkage between obesity and a marker near the tumor necrosis factor alfa locus in Pima Indians. J Clin Invest 1995;96:158-162.
89. Ogawa Y, Masuzaki H, Isse N, Okazaki T, Mori K, Shigemoto M, Satoh N, Tamura N, Hosohoda K, Yoshimasa Y, Jingami H, Kawada T, Nakao K: Molecular cloning of rat obese cDNA and augmented gene expression in genetically obese Zucker fatty (fa/fa) rats. J Clin Invest 1995;96:1647-1652.
90. Ohlson L, Larsson B, Svardsudd K, Welin L, Eriksson H, Wilhelmsen L, Bjorntorp P, Tibblin G: The influence of body fat distribution on the incidence of diabetes mellitus: 13.5 years of follow-up of the participants in the study of men born in 1913. Diabetes 1985;34:1055-1058.
91. O'Rahilly S, Turner R, Matthews D: Impaired pulsatile secretion of insulin in relatives of patients with non-insulin-dependent diabetes mellitus. N Engl J Med 1988;318:1255-1230.
92. Orho M, Nikula-Ijäs P, Schalin-Jäntti C, Permutt M, Groop L: Isolation and characterization of the human muscle glycogen synthase gene. Diabetes 1995;44:1099-1105.
93. Pelleymounter M, Cullen M, Baker M, Hecht R, Winters D, Boone T, Collins F: Effects of the obese gene product on body weight regulation in ob/ob mice. Science 1995;269:540-542.
94. Pimenta W, Korytkowski M, Mitrakou A, Jenssen T, Yki-Järvinen H, Evron W, Dailey G, Gerich J: Pancreatic beta-cell dysfunction as the primary genetic lesion in NIDDM. JAMA 1995;273:1855-1861.
95. Ptacek L, Johnson K, Griggs R: Genetics and physiology of myotonic muscle disorders. N Engl J Med 1993;328:482-489.
96. Puhakainen I, Koivisto V, Yki-Järvinen H: No reduction in total hepatic glucose output by inhibition of gluconeogenesis with ethanol in NIDDM patients. Diabetes 1991;40:1319-1327.
97. Ravussin E, Lillioja S, Knowler W, Christin L, Freymond D, Abbott W, Boyce V, Howard B, Bogardus C: Reduced rate of energy expenditure as a risk factor for body-weight gain. N Engl J Med 1988;318:467-472.
98. Reaven G: Role of insulin resistance in human disease. Diabetes 1988;37:1595-1607.
99. Reynisdotter S, Wahrenberg H, Carlström K, Rössner S, Arner P: Catecholamine resistance in fat cells of women with upper-body obesity due to decreased expression of beta-2-adrenoceptors. Diabetologia 1994;37:428-435.
100. Rich S, French L, Sprafka J, Clements J, Goetz F: HLA-associated susceptibility to type 2 diabetes mellitus: The Wadena city health study. Diabetologia 1993;36:234-238.
101. Rotwein P, Chirgwin J, Province M, Knowler W, Pettit D, Cordell B, Goodman H, Permutt M: Polymorphism in the 5′-flanking region of the human insulin gene: A genetic marker for non-insulin-dependent diabetes mellitus. N Engl J Med 1983;308:65-71.
102. Saghizadeh M, Ong J, Garvey W, Henry R, Kern P: The expression of TNFalfa by human muscle. Relationship to insulin resistance. J Clin Invest 1996;97:1111-1116.
103. Schalin-Jäntti C, Härkönen M, Groop L: Impaired activation of glycogen synthase in people at increased risk for developing NIDDM. Diabetes 1992;41:598-604.
104. Seldin M, Mott D, Bhat D, Petro A, Kuhn C, Kingsmore S, Bogardus C, Opara E, Feinglos M, Surwit R: Glycogen synthase: A putative locus for diet-induced hyperglycemia. J Clin Invest 1994;94:1-8.
105. Serjeantson S, Owerbach D, Zimmet P, Nerup J, Thoma K: Genetics of diabetes in Nauru: Effects of foreign admixture, HLA antigens, and the insulin-gene linked polymorphism. Diabetologia 1983;25:13-17.
106. Shimokawa K, Kadowaki H, Sakura H, Otabe H, Hagura R, Kosaka K, Yazaki Y, Akanuma Y, Kadowaki T: Molecular scanning of the glycogen synthase and insulin receptor substrate-1 genes in Japanese subjects with non-insulin-dependent diabetes mellitus. Biochem Biophys Res Commun 1994;202:463-469.
107. Skarfors E, Selenus K, Lithell H: Risk factors for developing non-insulin-dependent diabetes mellitus: A 10-year follow-up of men in Uppsala. Br Med J 1991;303:755-760.
108. Stephens T, Basinski M, Bristow P, Bue-Valleskey J, Burgett S, Craft L, Hale J, Hoffmann J, Hsiung H, Kriauciunas A, MacKellar W, Rosteck P Jr, Schoner B, Smith D, Tinsley F, Zhang X-Y, Heiman M: The role of neuropeptide Y in the antiobesity action of the obese gene product. Nature 1995;377:530-532.
109. Storlien L, Jenkins A, Chisholm D, Pasqoe W, Kohouri S, Kraegen E: Influence of dietary fat composition on development of insulin resistance in rats. Relationship to muscle triglyceride and omega-3 fatty acids in muscle phospholipid. Diabetes 1991;40:280-289.
110. Tartaglia L, Dembski M, Weng X, Deng N, Culpepper J, Devos R, Richards G, Campfield L, Clark F, Dees J, Muir C, Sanker S, Moriarty A, Moore K, Smutko J, Mays G, Woolf E, Monroe C, Tepper R: Identification and expression cloning of a leptin receptor, ob-R. Cell 1996;83:1263-1271.
111. Taylor S, Kadowaki T, Kadowaki H, Accili D, Cama A, Mc Keon C: Mutations in the insulin receptor gene in insulin-resistant patients. Diabetes Care 1991;13:257-259.
112. Thomas F, Balkau B, Vauzelle-Kevroedan F, Papoz L, Group C-IZS: Maternal effect and familial aggregation of NIDDM. The CODIAB study. Diabetes 1994;43:63-67.
113. Tuomi T, Groop L, Zimmet P, Rowley M, Knowles W, Mackay I: Antibodies to glutamic acid decarboxylase (GAD) identify latent IDDM in patients with onset of diabetes after the age of 35 years. Diabetes 1993;42:359-362.
114. Tuomilehto-Wolf E, Tuomilehto J, Hitman G, Stengård J, Nissinen A, Pekkanen J, Kivinen P, Karsalo E, Karvonen M: Genetic susceptibility to non-insulin-dependent diabetes mellitus and glucose intolerance are located in HLA region. Br Med J 1993;307:155-159.
115. Turton M, O'Shea D, Gunn I, Beak S, Edwards C, Meeran K, Choi S, Taylor G, Heath M, Lambert P, Wilding P, Smith D, Ghatei M, Herbert J, Bloom S: A role for glucagon-like-peptide-1 in the central regulation of feeding. Nature 1996;379:69-72.
116. Vaag A, Henriksen J, Beck-Nielsen H: Decreased activation of glycogen synthase in skeletal muscle of young nonobese Caucasian first-degree relatives of patients with non-insulin-dependent diabetes mellitus. J Clin Invest 1992;89:782-788.
117. Walston J, Silver K, Bogardus C, Knowler W, Celi F, Austin S, Manning B, Strosberg D, Stern M, Raben N, Sorkin J, Roth J, Shuldiner A: Time of onset of non-insulin-dependent diabetes mellitus and genetic variation in the pyadrenergic-receptor gene. N Engl J Med 1995;333:343-347.
118. van den Ouwenland J, Lemkes H, Ruitenbeek W, Sandkuijl L, deVijlder M, Struyvenberg P, van de Kemp J, Maassen J: Mutation in mitochondrial tRNA (Leu(UUR)) gene in a large pedigree with maternally transmitted type II diabetes mellitus and deafness. Nature Genet 1992;1:368-371.
119. Warrant J, Martin B, Krolewski A, Soeldner J, Kahn R: Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in offspring of diabetic parents. Ann Intern Med 1990;113:909-915.
120. Vaxillaire M, Boccio V, Philippi A, Vigouroux C, Terwilliger J, Passa P, Beckman J, Velho G, Lathrop G, Froguel P: A gene for early-onset non-insulin-dependent diabetes mellitus (maturity-onset diabetes of the young) maps to chromosome 12q. Nature Genets 1995;9:418-423.
121. Velho G, Froguel P, Clement K, Pueyo M, Rakotoambinina B, Zouali H, Passa P, Cohen D, Robert J-J: Primary pancreatic beta-cell secretory defect caused by mutations in glucokinase gene in kindreds of maturity onset diabetes of the young. Lancet 1992;340:444-448.
122. Wells A, Sutcliffe I, Johnson A, Taylor R: Abnormal activation of glycogen synthase in fibroblasts from NIDDM patients: Evidence for an abnormality specific to glucose metabolism. Diabetes 1993;42:583-589.
123. Vessby B, Tengblad S, Lithell H: Insulin sensitivity is realted to the fatty acid composition of serum lipids and skeletal muscle phospholipids in 70-year-old men. Diabetologia 1994;37:1044-1050.
124. Widén E, Ekstrand A, Saloranta C, Franssila-Kallunki A, Eriksson J, Schalin-Jäntti C, Groop L: Insulin resistance in type 2 diabetic patients with hypertriglyceridemia. Diabetologia 1992;35:1140-1145.
125. Widén E, Lehto M, Kanninen T, Walston J, Shuldiner A, Groop L: Association of a polymorphism in the beta-3-adrenergic-receptor gene with features of the insulin resistance syndrome in Finns. N Engl J Med 1995;333:348-351.
126. Vuorinen-Markkola H, Yki-Järvinen H: Hyperuricemia and insulin resistance. J Clin Endocrinol Metab 1994;78:25-28.
127. Yki-Järvinen H: Acute and chronic effects of hyperglycemia on glucose metabolism. Diabetologia 1990;33:579-585.
128. Zhang Y, Proenca R, Maffei M, Baron M, Leopold L, Friedman J: Positional cloning of the mouse obese gene and its human homologue. Nature 1994;372:425-432.
129. Zimmet P: Diabetes care and prevention: Around the world in 80 days; in Rifkin HCJ, Taylor SI (eds): Diabetes 1991: Amsterdam, Elsevier, 1991, pp 721-729.
130. Zouali H, Velho G, Froguel P: Polymorphism of the glycogen synthase gene and non-insulin-dependent diabetes mellitus. N Engl J Med 1993;328:1568.
131. Zurlo F, Lillioja S, Esposito-Del Puente A, Nyomba L, Raz I, Saad M, Swinburn B, Bogardus C, Ravussin E. Low ratio of fat to carbohydrate oxidation as predictors of weight gain: Study of 24h RQ: Am J Physiol 1990;259:E650-E657.
132. Yamagata K, Oda N, Kaisaki PJ, et al: Mutations in the hepatocyte nuclear factor-1α gene in maturity-onset diabetes of the young (MODY3). Nature 1996;384:455-458.
133. Yamagata K, Furuta H, Oda N, et al: Mutations in the hepatocyte nuclear factor-4α gene in maturity-onset diabetes of the young (MODY1). Nature 1996;384:458-460.